ADC Therapeutics S.A.

ADCT Stock Healthcare Biotechnology
$1.04
+0.07 (+7.76%)
Price as of Aug 25, 2026 market close

Performance

1 Month
-8.8%
3 Months
-70.4%
YTD
-70.5%
1 Year
-67.3%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
92.3%
Largest decline max drawdown, since Aug 2025
-80.3%
Risk-adjusted return Sharpe ratio, 1-year
-0.62

Own ADCT?

See how ADCT contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.